Kusajili – Clinical trials directory

Result of your search per sponsor: Stephan Kraehenbuehl, Prof. Dr

Woman and Man Max 99 years
Stephan Kraehenbuehl, Prof. Dr Update Il y a 4 ans

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) The purpose of this study is to define the dose for a Phase II study and to investigate safety and tolerability of intravenous administration of recombinant soluble human Angiotensin Conve...

Country Switzerland
organs None
Specialty None

Closed trial

More information